Papers
2
Total Citations
45
H-Index
2
About
Micol De Simoni is a biomedical engineer and researcher whose work sits at the intersection of nuclear medicine, surgical robotics, and oncology. Her primary research focus is the development of novel detection technologies for radioguided surgery, particularly for prostate cancer. De Simoni’s most notable contribution is the design and first ex vivo evaluation of a DROP-IN beta probe for robot-assisted surgery, specifically targeting ⁶⁸Ga-PSMA—a PET isotope that emits beta particles. This innovation addresses a critical limitation of conventional gamma probes, which are less sensitive for detecting small or occult lesions. Her 2020 study, which has accumulated over 40 citations, demonstrated the probe’s feasibility using prostate cancer specimens, paving the way for more precise, real-time tumor detection during robotic procedures. This work is a significant step toward integrating beta-emitting PET tracers into surgical workflows, potentially improving the completeness of tumor resection. De Simoni’s research is highly interdisciplinary, bridging engineering, radiochemistry, and clinical surgery, and her contributions are helping to define the next generation of intraoperative imaging tools.
Research Focus
Key Achievements
Top Papers
- 1
- 2